The stock of Divis Laboratories is up 10 per cent over the last couple of trading sessions on expectations that the worst is behind and the company could see a sequential growth in the March quarter of the 2022-23 financial year (Q4FY23). The stock witnessed the highest downgrades among Nifty50 index stocks with earnings cuts over a third after the Q3FY23 results. The company had posted a 32 per cent drop in revenues over the year ago quarter in Q3FY23 and 8 per cent sequentially, which was sharply lower than Street expectations.
When she does show up an hour into the movie, Alia's confidence is hard to miss, notes Sukanya Verma.
In contrast with their strong performance in 2020 and 2021, pharmaceutical and healthcare funds experienced a decline in 2022, with returns plummeting by an average 9.8 per cent. This trend has continued in the current year, with year-to-date return remaining in the negative (-4.9 per cent). In the past three months, pharma funds have been hit hard, experiencing a 7.9 per cent decline.
Rajkummar Rao and Adarsh Gourav get into the nutty mode easily and carry off the dark comedy without overacting, while Dulquer Salmaan looks bored, observes Deepa Gahlot.
This tangled tale of good versus evil could have been far more intriguing, observes Mayur Sanap.
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.
Notwithstanding the fact that the country's pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders predict that the overall domestic pharma industry will only witness a price hike of 5-6 per cent. This is attributed to higher competitive intensity in the market. Krishnakumar V, executive director and chief operating officer (CEO) of Eris Lifesciences, a domestic-focused pharma company, noted that the NLEM segment experienced growth suppression of around 150 basis points due to price reductions during the January to July period this year.
The headline for corporate profit growth has been very encouraging in the July-September quarter (Q2) of 2023-24 (FY24), with the combined net profit of listed companies up by 38 per cent year-on-year. However, the earnings distribution has been very lopsided, with most of the growth coming from public-sector oil-marketing companies (OMCs), banks, non-bank lenders, automobile (auto) companies, and cement producers. By comparison, companies from information technology services, fast-moving consumer goods (FMCG), retail, and consumer durables were disappointed, experiencing a sharp slowdown in net sales growth and a relatively muted increase in reported net profit.
DC is keen on rebooting its superhero universe, and by all means, The Flash is a decent step in that direction, notes Mayur Sanap.
Cement companies witnessed speculative support from investors through FY23 amid hopes of a rebound. After capex announcements in the FY24 Budget, there was further interest due to expectations that government expenditure would boost earnings, besides a generic macro-recovery. Cement earnings were under pressure in FY22 and FY23 due to high raw material and fuel costs; muted demand prevented them passing on the higher cost.
Indian drug firms continue to work closely with the FDA, and most have also appointed consultants to help them grasp the regulatory minutiae in the US.
After securing a euro 150 million Credit line for solar energy finance from a German financial institution, State Bank of India is in talks with european Investment Bank for about euro 200 million to fund climate finance. Recently the country's largest lender obtained euro 150 million in green funding from German government-owned KFW on soft terms and a long repayment period. SBI will use funds to finance solar energy projects.
Deepa Gahlot lists some interesting made-for-OTT hostage dramas that you can watch.
Pfizer Inc and its group companies filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy's Laboratories alleging that the Indian drug-makers were planning separately to come out with generic versions of its blockbuster multi-billion dollar drug Ibrance (palbociclib) before expiration of its patent.
Reliance Jio Infocomm (RJIL) has written to the Telecom Regulatory Authority of India (Trai) stating that a recent complaint against it by Bharti Airtel is a deliberate, malicious attempt at defaming RJIL's consumer-friendly tariff. RJIL has also asked the regulator to warn Airtel against 'making such frivolous complaints in the future'. The move is in response to Airtel recently requesting Trai to bring content aired through broadband under the regulatory fold and keep a check against discriminatory bundling tactics.
Indian drug firms get a shot in the arm in the $12 bn Australian drug market as the Therapeutic Goods Administration (TGA), Australia agrees to accelerate the drug approval process in that country for Indian players who already have an approved plant and product from one of the stringent regulatory authorities like US, EU or Canada. From current sales of $340 mn, the Indian firms can see a significant upside in sales; felt Dinesh Dua, former chairman of the Pharmaceutical Exports Promotion Council of India (Pharmexcil), and the MD of Nectar Lifesciences. He highlighted that only 12 percent of the Australian drug market is generic, as against 80-90 per cent in the US or EU. Of this $1.5 bn generic drug market in India, Indian companies have a small share.
The Supreme Court said on Thursday it will examine the larger constitutional issue of challenge to the validity of extrajudicial divorce like 'talaq-e-hasan' among Muslims.
If you are looking for a smart popcorn horror to watch with friends, this is a fairly enjoyable romp.
The subsidence zone is located at central Joshimath only including the Army Helipad and Narsingh temple, the satellite images revealed.
Glenmark Pharmaceuticals Ltd on Tuesday said it has acquired the approved generic versions of certain over-the-counter drugs from Wockhardt Ltd in the US. The acquisition by the company's fully-owned subsidiary Glenmark Pharmaceuticals Inc, USA includes the approved abbreviated new drug applications (ANDAs) for famotidine tablets, 10 mg and 20 mg used to treat and prevent ulcers in the stomach and intestine, the company said in a statement. The company, however, did not disclose the financial details.
It's important for GenZers to know what they are getting themselves into: If you're going on a date, clearly state your intentions ahead of time! That way, there won't be any surprises that could disrupt the flow of the evening, alerts Sybil Shiddell, country manager India, Gleeden, a discreet extra marital dating Web site.
If you thought you loved Mohanlal and that you could watch him do anything for 120 minutes, Alone is your chance to put your love to the test, observes Mayur Sanap.
Four cities, including, Delhi, Mohali, Hyderabad and Ahmedabad have been issued ticket advisories with fans being banned from carrying protest banners.
No matter what field you work in or what stage of your career you are in, metrics-based data always augments your CV, alerts Neelabh Shukla, Chief Business Officer, MyCareernet.
Things are looking up for engineering firms and Siemens is likely to be one of the leading beneficiaries. Apart from the generic revival in activity, which is expected to continue through the 2023-24 financial year (FY24), the Budget has a strong infrastructure thrust, which works in Siemens' favour. The company reported a standalone Ebitda (earnings before interest, tax, depreciation and amortisation) of Rs 550 crore (up 66 per cent year-on-year or YoY) in Q1FY23 (Siemens follows the October-September accounting year).
Hospitals to recover from sluggish Q3; diagnostics' growth rate at pre-Covid levels.
Overestimation of AI can lead to an excessive level of trust and the spread of disinformation. ChatGPT's replies are riddled with factual errors, hidden in eloquent, grammatically correct sentences. This leads to a hallucination of truth, explains Kumar Abishek.
An Indian pharmaceutical company is gearing up to sell a cheap version of the leading patented antiviral flu drug Tamiflu to emerging economies, in a move that will pitch intellectual property rights against affordable access to medicines.
Of late, crime, politics, corruption and hate have been leaking out of every streaming platform. By the time Garmi drops, fatigue has already set in, observes Deepa Gahlot.
Janhvi Kapoor's latest film Bawaal has made her quite the globetrotter.
'With Trump, the relationship was very transactional, whereas with President Biden it is very structured.'
The real scene stealer of Ajay-Tabu's Fury Road is Deepak 'Deadly' Dobriyal, applauds Sukanya Verma.
The third-quarter financials didn't excite market watchers. But equity investors can still make money if they invest in the right stocks.
Domestic-focused agricultural chemical (agrochem) companies could face near-term headwinds, given the worries on the El Nio effect on monsoons, higher inventory, and pressure on margins. Some of these were reflected in the October-December quarter (third quarter, or Q3) results of companies and may impact them in the current quarter (fourth quarter, or Q4) as well. Nuvama Research pointed out that the sector witnessed mixed performance during the quarter as global agrochem and domestic fertiliser companies maintained growth momentum, while adverse agronomical conditions and excess channel inventory weighed on domestic market volume offtake.
After the success of Lagey Raho for Alpenliebe, Perfetti is looking to play with generic themes and sticky tag-lines for Center Fresh as well.
Prime Minister Narendra Modi on Saturday got emotional after interacting with one of the beneficiaries of Pradhan Mantri Bhartiya Janaushadhi Pariyojana who got paralysis attack a couple of years ago and is now recovering from the generic medicine provided under the scheme.
Valentine's day is nerve-wracking only because people make it so; stop putting pressure on yourself to make it perfect, suggests Ravi Mittal, CEO, Quack Quack, an online dating app.
Once a difficult market to crack, in recent years, China has relatively opened up its drug market, enacting reforms and speeding up approval time.
We expect the authorities to strictly follow the due procedure under the law, the SC said.
The 'been there, seen that' feeling is so strong with Ved that it punctures any possibility of a compelling watch, Mayur Sanap tells us.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances